Now showing items 1-20 of 24
| Title | Author(s) | Journal | Issue Date | Type |
|---|---|---|---|---|
| DC-SIGN increases the affinity of HIV-1 envelope glycoprotein interaction with CD4 | Hijazi, K.; Wang, Y.; Scala, C.; Jeffs, S.; Longstaff, C.; Stieh, D.; Haggarty, B.; Vanham, G.; Schols, D.; Balzarini, J.; Jones, I. M.; Hoxie, J.; Shattock, R.; Kelly, C. G. | PLoS ONE | 2011 | Article-E |
| Differential activity of candidate microbicides against early steps of HIV-1 infection upon complement virus opsonization | Jenabian, M. A.; Saidi, H.; Charpentier, C.; Bouhlal, H.; Schols, D.; Balzarini, J.; Bell, T. W.; Vanham, G.; Belec, L. | AIDS Research and Therapy | 2010 | Article-E |
| Role of dendritic cells in HIV-immunotherapy | Van Gulck, E.; Van Tendeloo, V. F.; Berneman, Z. N.; Vanham, G. | Current HIV Research | 2010 | Article |
| Polyelectrolyte capsules-containing HIV-1 p24 and poly I:C modulate dendritic cells to stimulate HIV-1-specific immune responses | De Haes, W.; De Koker, S.; Pollard, C.; Atkinson, D.; Vlieghe, E.; Hoste, J.; Rejman, J.; De Smedt, S.; Grooten, J.; Vanham, G.; Van Gulck, E. | Molecular Therapy | 2010 | Article |
| Rational design of HIV vaccine and microbicides: report of the EUROPRISE annual conference | Wahren, B.; Biswas, P.; Borggren, M.; Coleman, A.; Da Costa, K.; De Haes, W.; Dieltjens, T.; Dispinseri, S.; Grupping, K.; Hallengard, D.; Hornig, J.; Klein, K.; Mainetti, L.; Palma, P.; Reudelsterz, M.; Seifried, J.; Selhorst, P.; Skold, A.; van Gils, M. J.; Weber, C.; Shattock, R.; Scarlatti, G. | Journal of Translational Medicine | 2010 | Article-E |
| Development of microbicides for the prevention of HIV transmission in an in vivo system of debdritic cells and CD4+ T cells with emphasis on synergistic activity and avoidance of viral resistance | Terrazas-Aranda, K. | 2009 | Dissertation | |
| Efficient in vitro expansion of human immunodeficiency virus (HIV)-specific t-cell responses by gag mRNA-electroporated dendritic cells from treated and untreated HIV type 1-infected individuals | Van Gulck, E. R.; Vanham, G.; Heyndrickx, L.; Coppens, S.; Vereecken, K.; Atkinson, D.; Florence, E.; Kint, I.; Berneman, Z. N.; Van Tendeloo, V. | Journal of Virology | 2008 | Article |
| Dendritic cells loaded with gag mRNA from HIV quasispecies for the development of a cellular therapeutic vaccine | Van Gulck, E. | 2008 | Dissertation | |
| Capture et transfert du VIH par les cellules de Langerhans et les cellules dendritiques interstitielles | Vanham, G. | 2007 | Chapter | |
| Carbohydrate-binding agents efficiently prevent dendritic cell-specific intercellular adhesion molecule-3-grabbing nonintegrin (DC-SIGN)-directed HIV-1 transmission to T lymphocytes | Balzarini, J.; Van Herrewege, Y.; Vermeire, K.; Vanham, G.; Schols, D. | Molecular Pharmacology | 2007 | Article |
| A dual chamber model of female cervical mucosa for the study of HIV transmission and for the evaluation of candidate HIV microbicides | Van Herrewege, Y.; Michiels, J.; Waeytens, A.; De Boeck, G.; Salden, E.; Heyndrickx, L.; van den Mooter, G.; de Béthune, M. P.; Andries, K.; Lewi, P.; Praet, M.; Vanham, G. | Antiviral Research | 2007 | Article |
| Replicative fitness of CCR5-using and CXCR4-using human immunodeficiency virus type 1 biological clones | Ariën, K. K.; Gali, Y.; El-Abdellati, A.; Heyndrickx, L.; Janssens, W.; Vanham, G. | Virology | 2006 | Article |
| Efficient stimulation of HIV-1-specific T cells using dendritic cells electroporated with mRNA encoding autologous HIV-1 Gag and Env proteins | Van Gulck, E.; Ponsaerts, P.; Heyndrickx, L.; Vereecken, K.; Moerman, F.; De Roo, A.; Colebunders, R.; Van den Bosch, G.; Van Bockstaele, D. R.; Van Tendeloo, V. F. I.; Allard, S.; Verrier, B.; Maranon, C.; Hoeffel, G.; Hosmalin, A.; Berneman, Z. W.; Vanham, G. | Blood | 2006 | Article |
| Cellular immunotherapy for cytomegalovirus and HIV-1 infection | Van den Bosch, G. A.; Ponsaerts, P.; Vanham, G.; Van Bockstaele, D. R.; Berneman, Z. N.; Van Tendeloo, V. F. I. | Journal of Immunotherapy | 2006 | Article |
| Pre-incubation of cell-free HIV-1 group M isolates with non-nucleoside reverse transcriptase inhibitors blocks subsequent viral replication in co-cultures of dendritic cells and T cells | Njai, H. F.; Lewi, P. J.; Janssen, C. G. M.; Garcia, S.; Fransen, K.; Kestens, L.; Vanham, G.; Janssen, P. A. J. | Antiviral Therapy | 2005 | Article |
| Ex vivo induction of viral antigen-specific CD8+ T cell responses using mRNA-electrophorated CD40-activated B cells | Van den Bosch, G. A.; Ponsaerts, P.; Nijs, G.; Lenjou, M.; Vanham, G.; Van Bockstaele, D. R.; Berneman, Z. N.; Van Tendeloo, V. F. I. | Clinical and Experimental Immunology | 2005 | Article |
| Exploring an in vitro model for prevention and post-exposure prophylaxis (PEP) of sexual HIV transmission | Van Herrewege, Y. | 2004 | Dissertation | |
| Activity of reverse transcriptase inhibitors in monocyte-derived dendritic cells: a possible in vitro model for postexposure prophylaxis of sexual HIV transmission | Van Herrewege, Y.; Penne, L.; Vereecken, C.; Fransen, K.; van der Groen, G.; Kestens, L.; Balzarini, J.; Vanham, G. | AIDS Research and Human Retroviruses | 2002 | Article |
| Metabolic activation of nucleoside and nucleotide reverse transcriptase inhibitors in dendritic and Langerhans cells | Balzarini, J.; Van Herrewege, Y.; Vanham, G. | AIDS | 2002 | Article |
| Dendritic cells, exposed to primary, mixed phenotype HIV-1 isolates preferentially, but not exclusively, replicate CCR5-using clones [letter] | Vanham, G.; Davis, D.; Willems, B.; Penne, L.; Kestens, L.; Janssens, W.; van der Groen, G. | AIDS | 2000 | Article |
Now showing items 1-20 of 24